Showing 1 - 20 results of 108 for search '"Deauville"', query time: 0.15s Refine Results
  1. 1
  2. 2

    CT radiomics to predict Deauville score 4 positive and negative Hodgkin lymphoma manifestations by Laura J. Jensen, Julian M. M. Rogasch, Damon Kim, Juliana Rießelmann, Christian Furth, Holger Amthauer, Bernd Hamm, Ingo G. Steffen, Thomas Elgeti, Sebastian N. Nagel

    Published 2022-11-01
    “…Target lesions were classified as Deauville score 4 positive (DS4+) or negative (DS4−) based on their SUVpeak and then segmented in NECT images. …”
    Get full text
    Article
  3. 3
  4. 4

    The use of Deauville criteria in follow-up assessment of response to therapy in extra-nodal Non-Hodgkin's lymphoma by Manar Hussein Abdel-Sattar, Omar Abdelaziz, Amr Othman Othman, Sherief Mohamed El-Refaei

    Published 2018-03-01
    “…Keywords: PET/CT, Extranodal non-hodgkin lymphoma, Deauville criteria, IHP (International Harmonizing Project)…”
    Get full text
    Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Value of 18F-FDG PET/CT Parameters and Deauville 5-point Scoring in Efficacy Evaluation and Prognosis Prediction of Diffuse Large B Cell Lymphoma Patients by YANG Ming, FENG Yanlin, XIAN Weijun, LU Shengnan, WANG Ying, LI Wen, HUANG Kemin

    Published 2020-08-01
    “…By univariate and multivariate analyses, there were statistical differences in 2-years PFS between ΔSUVmax < 10.6, MTV < 30.1 cm3, Deauville score < 4, BCL-6(-) groups and ΔSUVmax≥10.6, MTV≥30.1 cm3, Deauville score≥4, BCL-6(+) groups (P < 0.05). …”
    Get full text
    Article
  15. 15

    Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study by Giuseppe Facondo, Mattia Serio, Gianluca Vullo, Maria Paola Bianchi, Sabrina Pelliccia, Alice Di Rocco, Tiziana Lanzolla, Maurizio Valeriani, Arianna Di Napoli, Agostino Tafuri, Maurizio Martelli, Mattia Falchetto Osti, Vitaliana De Sanctis

    Published 2023-05-01
    “…Background: In order to evaluate the efficacy of residual site radiation therapy (RSRT) in terms of progression-free survival (PFS) and overall survival (OS) in patients with primary mediastinal lymphoma (PMBCL) with Deauville Score 4 (DS 4) following rituximab and chemotherapy treatment (R-ICHT). …”
    Get full text
    Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20